Study provides roadmap to more personalized cancer treatment
Thursday, December 22, 2016 - 16:11
in Health & Medicine
People with advanced head and neck squamous cell carcinoma and the KRAS-variant inherited genetic mutation have significantly improved survival when given a short course of the drug cetuximab in combination with standard chemotherapy and radiation, research has found.